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SHORT REPORT
Complement C5a is present in CSF of human newborns and is elevated
in association with preterm birth
Rozalia Pataky1 , Forbes A. Howie1, Guillermina Girardi2*, and James P. Boardman1*
1MRC Centre for Reproductive Health, University of Edinburgh, Queen’s Medical Research Institute, Edinburgh, UK and 2Department of Women’s
Health, King’s College London, St Thomas’ Hospital, London, UK
Abstract
Neuroinflammation contributes to developmental brain injury associated with preterm birth,
but the mediators that drive it are incompletely understood. Previous studies have shown that
complement C5a is present and injurious in the brains of foetal mice exposed to preterm
labour. Here, we demonstrate that C5a is present in the cerebrospinal fluid of newborn human
infants and that levels are elevated in those born preterm. The difference is not explained by
systemic infection. Complement activation in the neonatal brain and its role as a potential
therapeutic target in preterm brain injury warrant further study. Activation in the neonatal brain
and its role as a potential therapeutic target for preterm brain injury warrants further study.
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Introduction
Preterm birth is strongly associated with a phenotype that
includes brain injury and long-term neurodevelopmental and
psychiatric impairments. Inflammation is a major contributor
to injury but the mediators and receptors involved are
uncertain [1].
The complement system is part of the innate immune
response to tissue injury and infection. Its four pathways all
result in the production of C5a, a potent anaphylatoxin that
binds to receptor C5aR to induce a range of inflammatory
activities. C5aR is widely expressed in the human central
nervous system [2], including in early development [3,4], and
C5a-C5aR signalling is implicated in the pathogenesis of
neurodegenerative and inflammatory CNS diseases in experi-
mental models [2]. In a mouse model of inflammation-
induced preterm birth C5a contributes to cortical neuronal
injury in utero, mediated through glutamate excitotoxicity [5].
Importantly, in this model, neuronal protection was achieved
through C5aR blockade, which raises the possibility that
modifying the complement system could be an effective
neuroprotective strategy. There are limited data on C5a in
human CNS disease and its role in developmental brain injury
is unknown. We aimed to determine whether C5a is present in
the cerebrospinal fluid (CSF) of newborns, and hypothesised
that levels would be increased among those born preterm.
Materials and methods
Participants
We recruited two groups of neonates from the Royal
Infirmary of Edinburgh between June 2014 and September
2015 who required CSF sampling, usually for the evaluation
of suspected sepsis: (1) preterm neonates (532 weeks’
gestation); and control infants born at437 weeks’ gestation.
Infants were not eligible if they had a chromosomal abnor-
mality, congenital malformation, or congenital infection.
Blood stream infection (BSI) at the time of CSF sampling
was defined as either (1) blood culture grew a pathogenic
bacterial species; or (2) the blood culture was negative or
grew coagulase negative Staphylococcus (CoNS) and the
infant had one or more signs of generalised infection (apnoea,
temperature instability, feeding intolerance, worsening
respiratory distress or hemodynamic instability) and the
attending neonatologist treated with IV antibiotics for  5 d.
Sequential cranial ultrasound examinations were per-
formed in preterm infants during the NICU stay, and the
worst grade of brain injury is reported (Supplemental
Table 1).
Written parental informed consent was obtained, and the
study was approved by the UK National Research Ethics
Service.
CSF samples
Lumbar puncture was carried out using a 22G spinal needle
and 4 drops of CSF were collected after clinical samples. The
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specimens were put on ice, centrifuged at 1000 rpm at 4 C for
10 min and the supernatant was frozen at 80 C for batch
analysis.
C5a measurement
Because C5a is rapidly cleaved to metabolite C5adesArg, we
measured C5adesArg to estimate C5a levels in thawed CSF
samples, using the C5a human ELISA kit (Hycult Biotech,
Uden, The Neatherlands.), following the instructions of the
manufacturer. The between batch coefficient of variation
(CV) was 3%; the within batch CV was 3.4% and 2.6%
across the two batches; and the lower limit of detection was
0.3 ng/ml.
Data analysis
Pearson’s Chi-squared test was used to compare the propor-
tions. The distribution of C5a values was tested for equality of
variance using Levene’s test, and group differences were
investigated using Student’s t-test. GLM ANOVA was used to
investigate possible confounding effects of systemic sepsis.
Analyses were performed using SPSS 21.0 (SPSS Inc.,
Chicago, IL).
Results
Participants
CSF for C5a measurements was obtained from 20 term and 17
preterm infants (Table 1), and individual participant’s blood,
CSF and diagnostic information were collected (Supplemental
Table 1).
Cerebrospinal fluid analysis
There was no significant difference in the proportion of
infants with CSF contaminated by blood defined as
RBC41000 cells/mm3: 50% preterm versus 42% of controls,
p¼ 0.73. The difference in proportion of infants with BSI in
each group was not statistically significant (p¼ 0.33), and
there was no significant difference in CSF RBC count
between infants with and without BSI (p¼ 0.559).
No infant had meningitis. CSF white cell counts were
within normal limits for age with the exception of one preterm
infant (PT1) who had a marked CSF lymphocytosis without
evidence of congenital infection, viral meningitis or neuro-
metabolic disease. This individual had florid intraparenchy-
mal echodensities on cranial ultrasound at the time of CSF
sampling, and later MRI revealed evolution of these to cystic
PVL. PT1’s CSF C5a concentration was 2.162 ng/ml, which
was within the upper 1.5 IQR of values for the preterm
group (Figure 1).
C5a in cerebrospinal fluid
C5a was present in the CSF of preterm and term infants, but
values were higher in preterms compared with controls: mean
CSF C5a concentration in preterm infants was 1.75 ng/ml
(range 0.42–5.24) versus 0.98 ng/ml (range 0.37–2.48) in term
infants, p¼ 0.006 (Figure 1).
When BSI at the time of sampling was included in the
GLM ANOVA, the effect of prematurity remained statistic-
ally significant (F-statistic 9.3, p¼ 0.005) and BSI was not
significant (F-statistic 1.23, p¼ 0.28).
Discussion
We demonstrated an increase in complement component C5a
in the CSF of preterm infants compared with infants born at
term. Our observations are consistent with the concept of a
perinatal inflammatory response in CSF after preterm birth
[6], and they provide a new potential therapeutic target for
reducing preterm brain injury.
The data build upon studies in mice that implicate the C5a-
C5aR pathway in the mechanism leading to increased
glutamate release and foetal brain injury associated with
intrauterine inflammation [5]. Further supportive evidence for
a neurotoxic role of C5a in developmental brain injury comes
from the observation that in utero exposure to malaria in mice
alters brain development and outcome through a C5a-C5aR
dependent pathway in a similar manner to the preterm birth
mouse model [7].
The median age of sampling the preterm group was day 10
after birth and for the term group it was 2 d. Given the rapid
turnover of CSF in the newborn (estimated to be 5 ml/kg/h), it
is likely that C5a, which can be synthesised by all central
nervous system cell types, is generated in the postnatal period
Table 1. Characteristics of neonates.
Preterms (n¼ 17) Term controls (n¼ 20)
Mean PMA age at birth/weeks (sd) 27.14 (2.14) 39.86 (1.86)
Mean PMA at sample/weeks collection (sd) 29.29 (2.86) 40.29 (2.0)
Day after birth life at sample collection/median (IQR) 10 (6-21) 2 (1-3)
Mean birth weight/g (sd) 1027 (299) 3484 (568)
BSI at the time of sample collection 10 (59%) 8 (40%)
Mechanical ventilation
Number of infants requiring mechanical ventilation prior to CSF sample 16* 5*
Number of ventilator days/median (IQR)* 1 (1-6) 2 (1-2)
Necrotising enterocolitis prior to CSF sample/number 1 0
Gender (M:F) 13:4 16:4
Antenatal steroid exposure (%) 16 (94%) 0
Antenatal MgSO4 (%) 12 (71%) 0
*Reasons for short-term mechanical ventilation in the preterm infants were respiratory distress syndrome or suspected/confirmed
bacterial sepsis; and in the term group all five cases were for suspected/confirmed bacterial sepsis and in one of these there was
evidence of meconium pneumonitis with air leak.
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for both groups. Specific co-morbidities of preterm birth such
as respiratory disease requiring mechanical ventilation and
necrotising enterocolitis are associated with a systemic
inflammatory response, and it is possible that these
pathologies as well as blood stream infection sepsis
(Table 1), could have contributed to an enhanced C5a
response in CNS that was established over a longer period
of time in the preterm group. This has clear implications for
timing of potential therapies designed to target dysregulated
C5a. Further studies with placental histopathology and cord
blood sampling would be required to determine whether
increased C5a is also a component of the foetal inflammatory
response syndrome as suggested by pre-clinical studies.
CSF samples from neonates may contain red blood cells,
which is most commonly due to contamination during
sampling or intraventricular haemorrhage. There was no
difference in the proportion of blood-stained taps (defined as
RBC41000/ml) between the preterm and term groups, and
there was no significant difference in the RBC count of CSF
samples taken from infants with and without systemic sepsis.
Therefore, it is unlikely that sample contamination by blood
explains the findings in CSF.
While some studies suggest physiological effects of C5a in
foetal brain development [4], many others have demonstrated
toxic effects of excessive C5a on neurons, glia and endothelial
cells in models of neurodegeneration, CNS injury and CNS
infection [2]. C5aR blockade augments the neuroprotective
effects of hypothermia in in vitro systems of ischaemia [8],
and pre-clinical studies show that inhibition of C5a generation
with eculizumab or treatment with statins attenuates perinatal
brain injury. These agents are already used in humans and
they are safe for mother and foetus [9,10].
In conclusion, we provide evidence of a perinatal inflam-
matory response in CSF with a modest but statistically
significant increase the concentration of complement split
product C5a in preterm infants compared to term infants. C5a
might be an important therapeutic target to reduce brain
injury associated with preterm birth and further investigation
is warranted.
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